Skip to main content

Advertisement

SpringerLink
Log in

SDF-1(CXCL12) polymorphisms in Egyptian patients with systemic lupus erythematosus (SLE): a pilot study

  • Original Article
  • Published:
Comparative Clinical Pathology Aims and scope Submit manuscript

Abstract

SDF-1(CXCL12) is a chemokine that plays an important role in the regulation of migration, proliferation, and differentiation of hematopoietic cells, as well as being involved in the homeostatic and inflammatory traffic of leukocytes. It was suggested that CXCL12 is a key molecule in the development of autoimmunity in the murine model of lupus. It has been demonstrated that SDF-1 has a G801A transition at position 801 in the 3′-untranslated region of the transcript, known as SDF-1-3′G801A. This polymorphism may have an important regulatory function via an increase in the biosynthesis of SDF-1 protein and has been reported in association with autoimmune diseases, such as type 1 diabetes and systemic sclerosis. We investigated the prevalence of SDF-1-3′G801A genotype in Egyptian patients with systemic lupus erythematosus (SLE) (n = 50) and healthy controls (HC) (n = 50) and its relation to SLE manifestations. We found a significant correlation between the SDF-1-3′G801A genotype and the following SLE features: photosensitivity, nephritis, serositis, and vasculitis, and also anticardiolipin antibodies. Our observations suggest that the SDF-1-3′-G801A genotype may be associated with some clinical and laboratory manifestations in patients with SLE.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  • Ao W, Zheng H, Chen XW et al (2011) Anti-annexin II antibody is associated with thrombosis and/or pregnancy morbidity in antiphospholipid syndrome and systemic lupus erythematosus with thrombosis. Rheumatol Int 31:865–869

    Article  CAS  PubMed  Google Scholar 

  • Balabanian K, Couderc J, Bouchet-Delbos L et al (2003) Role of the chemokine stromal cell-derived factor 1 in autoantibody production and nephritis in murine lupus. J Immunol 170:3392–3400

    Article  CAS  PubMed  Google Scholar 

  • Burger JA, Kipps TJ (2006) CXCR4: a key receptor in the crosstalk between tumor cells and their microenvironment. Blood 107:1761–1767

    Article  CAS  PubMed  Google Scholar 

  • Chang SC, Lin PC, Yang SH et al (2009) SDF-1 alpha G801A polymorphism predicts lymph node metastasis in stage T3 colorectal cancer. Ann Surg Oncol 16:2323–2330

    Article  PubMed  Google Scholar 

  • Chung SH, Seki K, Choi BI et al (2010) CXC chemokine receptor 4 expressed in T cells plays an important role in the development of collagen-induced arthritis. Arthritis Res Ther 12:R188

    Article  PubMed Central  PubMed  Google Scholar 

  • Crispín JC, Hedrich CM, Tsokos GC (2013) Gene-function studies in systemic lupus erythematosus. Nat Rev Rheumatol 9:476–484

    Article  PubMed  Google Scholar 

  • Dommange F, Cartron G, Espanel C, GOELAMS Study Group et al (2006) CXCL12 polymorphism and malignant cell dissemination/tissue infiltration in acute myeloid leukemia. FASEB J 20:1913–1915

    Article  CAS  PubMed  Google Scholar 

  • Dooley MA (2007) Clinical and laboratory features of lupus nephritis. In: Wallace DJ, Hahn BH (eds) Dubois’ lupus erythematosus, 7th edn. Lippincott Williams & Wilkins, Philadelphia, pp 1112–30

    Google Scholar 

  • Günther C, Meurer M, Stein A et al (2009) Familial chilblain lupus—a monogenic form of cutaneous lupus erythematosus due to a heterozygous mutation in TREX1. Dermatology 219:162–166

    Article  PubMed  Google Scholar 

  • Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40:1725

    Article  CAS  PubMed  Google Scholar 

  • Juarez J, Bendall L, Bradstock K (2004) Chemokines and their receptors as therapeutic targets: the role of the SDF-1/CXCR4 axis. Curr Pharm Des 10:1245–1259

    Article  CAS  PubMed  Google Scholar 

  • Khademi B, Razmkhah M, Erfani N et al (2008) SDF-1 and CCR5 genes polymorphism in patients with head and neck cancer. Pathol Oncol Res 14:45–50

    Article  CAS  PubMed  Google Scholar 

  • Kim HL, Lee D, Yang SH et al (2002) The polymorphism of monocyte chemoattractant protein-1 is associated with the renal disease of SLE. Am J Kidney Dis 40:1146–1152

    Article  CAS  PubMed  Google Scholar 

  • Kyttaris VC, Katsiari CG, Juang YT et al (2005) New insights into the pathogenesis of systemic lupus erythematosus. Curr Rheumatol Rep 7:469–475

    Article  CAS  PubMed  Google Scholar 

  • Lian LH, Kee BP, Ng HL et al (2011) Lack of association between RANTES-28, SDF-1 gene polymorphisms and systemic lupus erythematosus in the Malaysian population. Genet Mol Res 10:2841–2850

    Article  CAS  PubMed  Google Scholar 

  • Lima G, Soto-Vegaa E, Atisha-Fregosoa Y et al (2007) MCP-1, RANTES, and SDF-1 polymorphisms in Mexican patients with systemic lupus erythematosus. J humimm 10:980–985

    Google Scholar 

  • Manetti M, Liakouli V, Fatini C et al (2009) Association between a stromal cell-derived factor 1 (SDF-1/CXCL12) gene polymorphism and microvascular disease in systemic sclerosis. Ann Rheum Dis 68:408–411

    Article  CAS  PubMed  Google Scholar 

  • Petty JM, Sueblinvong V, Lenox CC et al (2007) Pulmonary stromal-derived factor-1 expression and effect on neutrophil recruitment during acute lung injury. J Immunol 178:8148–8157

    Article  CAS  PubMed  Google Scholar 

  • Pons-Estel GJ, Alarcón GS, Scofield L et al (2010) Understanding the epidemiology and progression of systemic lupus erythematosus. Semin Arthritis Rheum 39:257–268

    Article  PubMed Central  PubMed  Google Scholar 

  • Robak E, Kulczycka L, Sysa-Jedrzejowska A et al (2007) Circulating proangiogenic molecules PIGF, SDF-1 and sVCAM-1 in patients with systemic lupus erythematosus. Eur Cytokine Netw 18:181–187

    CAS  PubMed  Google Scholar 

  • Rosalind RG, David AI (2003) Systemic lupus erythematosus measures: British Isles Lupus Assessment Group (BILAG), European Consensus Lupus Activity Measurement (ECLAM), Systemic Lupus Activity Measure (SLAM), Systemic Lupus Erythematosus Disease Activity Measure (SLEDAI), and Systemic Lupus International Collaborating Clinics/American College of Rheumatology-Damage Index (SLICC/ACR-DI; SDI). Arthritis Care Res 49:S225–S233

  • Rovin BH (2008) The chemokine network in systemic lupus erythematous nephritis. Front Biosci 13:904–922

    Article  CAS  PubMed  Google Scholar 

  • Su YJ, Huang CR, Chang WN et al (2011) The association between autoantibodies and peripheral neuropathy in lupus nephritis. BioMed Research Int 2014:524940

    Google Scholar 

  • Wang A, Fairhurst AM, Tus K et al (2009) CXCR4/CXCL12 hyperexpression plays a pivotal role in the pathogenesis of lupus. J Immunol 82:4448–4458

    Article  Google Scholar 

  • Warchol T, Lianeri M, Lacki JK et al (2010) SDF1-3′ G801A polymorphisms in Polish patients with systemic lupus erythematosus. Mol Biol Rep 37:3121–3125

    Article  CAS  PubMed  Google Scholar 

  • Werner L, Guzner-Gur H, Dotan I (2013) Involvement of CXCR4/CXCR7/CXCL12 interactions in inflammatory bowel disease. Theranostics 3(1):40–46

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Wu FX, Luo XY, Wu LJ et al (2012) Association of chemokine CXCL12-3′G801A polymorphism with systemic lupus erythematosus in a Han Chinese population. Lupus 21:604–610

    Article  PubMed  Google Scholar 

  • Ye DQ, Hu YS, Li XP et al (2005) The correlation between monocyte chemoattractant protein-1 and the arthritis of systemic lupus erythematosus among Chinese. Arch Dermatol Res 296:366–371

    Article  CAS  PubMed  Google Scholar 

Download references

Conflict of interest

Sherif Yousry, Gehan Shahin, Doaa El Demerdash, and Noha EL Husseiny declare that they have no conflict of interest.

Author information

Authors and Affiliations

  1. Clinical Pathology Department, Kasr Al-Ainy Hospital, Faculty of Medicine, Cairo University, Cairo, Egypt

    Sherif Yousry & Gehan Shahin

  2. Internal Medicine Department, Kasr Al-Ainy Hospital, Faculty of Medicine, Cairo University, Cairo, Egypt

    Doaa El Demerdash & Noha EL Husseiny

Authors
  1. Sherif Yousry
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Gehan Shahin
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Doaa El Demerdash
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Noha EL Husseiny
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Doaa El Demerdash.

Additional information

Authors’ contributions

Meticulous laboratory work was done under the supervision of Dr. Sherif Yousry and Dr. Gehan Shahin. Statistical work was done and reviewed by Dr. Noha EL Husseiny. Drafting of the article by Doaa El Demerdash, and all the authors revised it.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Yousry, S., Shahin, G., El Demerdash, D. et al. SDF-1(CXCL12) polymorphisms in Egyptian patients with systemic lupus erythematosus (SLE): a pilot study. Comp Clin Pathol 24, 1535–1540 (2015). https://doi.org/10.1007/s00580-015-2112-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00580-015-2112-1

Keywords

Search

Navigation